Notably, in breast cancer cells lines, HIF-1α has been reported to repress transcription of the estrogen hormone receptor, ERα [48], and V-ATPase inhibition was reported to increase HIF-1α protein levels in several other cancer cell lines [49, 50]. This evidence concerns the gene ESR1 and breast carcinoma.